Cohen J. 2001. Smallpox vaccinations: how much protection remains? Science 294(5544):985.
Crotty S, Felgner P, Davies H, Glidewell J, Villarreal L, Ahmed R. 2003. Cutting edge: long-term B cell memory in humans after smallpox vaccination. Journal of Immunology 171(10):4969-4973.
DHHS (Department of Health and Human Services). 2001. News Release: HHS Awards $428 Million Contract to Produce Smallpox Vaccine. Acambis/Baxter Will Produce 155 million Doses by End of 2002. [Online] Available at http://www.hhs.gov/news/press/2001pres/20011128.html. Accessed January 26, 2005.
Eichner M. 2003. Analysis of historical data suggests long-lasting protective effects of smallpox vaccination. American Journal of Epidemiology 158:717-723.
Fauci A. 2003. NIH’s Role in Implementing a Smallpox Vaccination Program. Testimony before the Senate Committee on Appropriations: Subcommittee on Labor, HHS, Education and Related Agencies, January 30, 2003.
Fauci AS. 2002. Smallpox vaccination policy—the need for dialogue. New England Journal of Medicine 346(17):1319-1320.
Fenner F, Henderson D, Arita A, Jezek Z, Ladnyi I. 1988. Smallpox and Its Eradication. Geneva: World Health Organization.
Frey SE, Couch RB, Tacket CO, Treanor JJ, Wolff M, Newman FK, Atmar RL, Edelman R, Nolan CM, Belshe RB. 2002. Clinical Responses to Undiluted and Diluted Smallpox Vaccine. New England Journal of Medicine 346(17):1265-1274.
Gani R, Leach S. 2001. Transmission potential of smallpox in contemporary populations. Nature 414(6865):748-751.